Business Context and Reporting Period
Company: CARLSMED, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2025
Reporting Period: Single event date (July 24, 2025)
Business Context: The Company is an emerging growth company incorporated in Delaware. This filing reports the closing of its initial public offering (IPO) of common stock (Trading Symbol: CARL) on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance data.
Material Changes
- Corporate Governance: On July 24, 2025, the Company filed its Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws.
- Effectiveness: These documents became effective immediately prior to the closing of the IPO.
- Regulatory Filing: The changes were approved by the Board of Directors and stockholders in connection with the Registration Statement on Form S-1 (File No. 333-288339).
Guidance, Outlook, and Risks
Management Commentary: The filing references the final prospectus dated July 22, 2025, for a detailed description of the capital stock provisions. No specific forward-looking guidance, outlook, or risk factors are detailed within the text of this 8-K summary.
Unusual Items: None reported in this specific filing text.
Investor Verification Checklist
- Verify the terms of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) attached to the filing.
- Review the final prospectus dated July 22, 2025, for the "Description of Capital Stock" and detailed IPO terms.
- Confirm the trading status of common stock (Symbol: CARL) on The Nasdaq Stock Market LLC.
- Check the Registration Statement on Form S-1 (File No. 333-288339) for comprehensive financial data not included in this 8-K.